← All peptides
Healing & Recovery
Research Chemical

Repair and Recovery Blend (Stable BPC-157 Arginate, TB-4 Fragment)

Also known as: Repair and Recovery Blend, Healing and Repair Research Blend (BPC-157, TB4 Frag 1-4, GHK-Cu)

A research blend pairing a stabilized arginate salt of BPC-157 with an active fragment of Thymosin Beta-4 to target soft-tissue and musculoskeletal repair. It is studied for accelerated wound healing and recovery.

Last updated

Mechanism of Action

BPC-157 promotes angiogenesis and tendon/ligament fibroblast outgrowth by upregulating VEGFR2 signaling, the nitric oxide system, and growth-factor receptor expression. The arginate salt form is intended to improve stability and solubility relative to the acetate. The Thymosin Beta-4 N-terminal fragment retains the actin-binding and cell-migration-promoting properties of the parent peptide, supporting cytoskeletal remodeling, keratinocyte and endothelial migration, and reduced inflammation. Together the components target the angiogenic, migratory, and anti-inflammatory phases of healing.

Half-life
Short for BPC-157 (minutes to a few hours in plasma); the TB-4 fragment is cleared on a similar short timescale.
Administration Routes
subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Studied for accelerated tendon, ligament, and muscle repair
  • Promotes angiogenesis and new tissue formation
  • May support cell migration during wound healing
  • Explored for reduced inflammation around injury sites
  • Combines two complementary regenerative peptides
  • Investigated for faster recovery between training bouts

Potential Side Effects

  • Injection-site redness, swelling, or discomfort
  • Lightheadedness or transient fatigue
  • Possible headache
  • Unknown effects from combining components
  • Sparse human safety data

Common Dosing

For research use only and not medical advice; component literature describes BPC-157 in the ~250-500 mcg range one to two times daily and Thymosin Beta-4 fragments in the low-milligram weekly range. Blend products vary by vendor and have no standardized protocol.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Active or suspected malignancy due to pro-angiogenic activity
  • Pregnancy and breastfeeding
  • Known hypersensitivity to any blend component
  • Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications

    2016

    View
  • Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues

    2005

    View
  • Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth

    2003

    View
  • The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

    2011

    View
  • Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice

    2003

    View

The arginate salt is intended to improve the peptide's stability and aqueous solubility compared with the more common acetate salt, while the active BPC-157 sequence remains the same.

The Thymosin Beta-4 fragment retains the actin-binding region that drives cell migration and tissue remodeling, complementing BPC-157's angiogenic and growth-factor effects.

No. It is a research chemical with no FDA approval; supporting evidence comes from preclinical and component-level studies.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.